Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash-to-Debt No Debt
SLP's Cash-to-Debt is ranked higher than
99% of the 2082 Companies
in the Global Health Information Services industry.

( Industry Median: 8.37 vs. SLP: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
SLP' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.11  Med: No Debt Max: No Debt
Current: No Debt
0.11
No Debt
Equity-to-Asset 0.73
SLP's Equity-to-Asset is ranked higher than
63% of the 1985 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. SLP: 0.73 )
Ranked among companies with meaningful Equity-to-Asset only.
SLP' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.25  Med: 0.84 Max: 0.91
Current: 0.73
-0.25
0.91
Interest Coverage 64.77
SLP's Interest Coverage is ranked lower than
52% of the 1570 Companies
in the Global Health Information Services industry.

( Industry Median: 140.00 vs. SLP: 64.77 )
Ranked among companies with meaningful Interest Coverage only.
SLP' s Interest Coverage Range Over the Past 10 Years
Min: 217.47  Med: No Debt Max: No Debt
Current: 64.77
217.47
No Debt
Piotroski F-Score: 5
Altman Z-Score: 18.44
Beneish M-Score: -2.45
WACC vs ROIC
-2.86%
43.26%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 33.66
SLP's Operating Margin % is ranked higher than
96% of the 2027 Companies
in the Global Health Information Services industry.

( Industry Median: 4.54 vs. SLP: 33.66 )
Ranked among companies with meaningful Operating Margin % only.
SLP' s Operating Margin % Range Over the Past 10 Years
Min: 19.82  Med: 35.23 Max: 40.43
Current: 33.66
19.82
40.43
Net Margin % 29.91
SLP's Net Margin % is ranked higher than
93% of the 2027 Companies
in the Global Health Information Services industry.

( Industry Median: 3.36 vs. SLP: 29.91 )
Ranked among companies with meaningful Net Margin % only.
SLP' s Net Margin % Range Over the Past 10 Years
Min: 15.44  Med: 24.38 Max: 32.05
Current: 29.91
15.44
32.05
ROE % 31.63
SLP's ROE % is ranked higher than
87% of the 1969 Companies
in the Global Health Information Services industry.

( Industry Median: 6.14 vs. SLP: 31.63 )
Ranked among companies with meaningful ROE % only.
SLP' s ROE % Range Over the Past 10 Years
Min: 13.79  Med: 20.22 Max: 23.85
Current: 31.63
13.79
23.85
ROA % 22.81
SLP's ROA % is ranked higher than
92% of the 2097 Companies
in the Global Health Information Services industry.

( Industry Median: 3.01 vs. SLP: 22.81 )
Ranked among companies with meaningful ROA % only.
SLP' s ROA % Range Over the Past 10 Years
Min: 11.84  Med: 17.08 Max: 18.23
Current: 22.81
11.84
18.23
ROC (Joel Greenblatt) % 391.87
SLP's ROC (Joel Greenblatt) % is ranked higher than
87% of the 2065 Companies
in the Global Health Information Services industry.

( Industry Median: 20.86 vs. SLP: 391.87 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
SLP' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 101.45  Med: 283.97 Max: 574.29
Current: 391.87
101.45
574.29
3-Year Revenue Growth Rate 25.40
SLP's 3-Year Revenue Growth Rate is ranked higher than
87% of the 1648 Companies
in the Global Health Information Services industry.

( Industry Median: 5.80 vs. SLP: 25.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
SLP' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 7 Max: 25.4
Current: 25.4
0
25.4
3-Year EBITDA Growth Rate 21.20
SLP's 3-Year EBITDA Growth Rate is ranked higher than
68% of the 1481 Companies
in the Global Health Information Services industry.

( Industry Median: 8.80 vs. SLP: 21.20 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
SLP' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 16 Max: 265.9
Current: 21.2
0
265.9
3-Year EPS without NRI Growth Rate 22.40
SLP's 3-Year EPS without NRI Growth Rate is ranked higher than
68% of the 1387 Companies
in the Global Health Information Services industry.

( Industry Median: 9.80 vs. SLP: 22.40 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
SLP' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 14.7 Max: 77.1
Current: 22.4
0
77.1
GuruFocus has detected 3 Warning Signs with Simulations Plus Inc SLP.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SLP's 30-Y Financials

Financials (Next Earnings Date: 2018-11-10 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2017

SLP Guru Trades in Q2 2017

Jim Simons 478,147 sh (-7.16%)
» More
Q3 2017

SLP Guru Trades in Q3 2017

Chuck Royce 362 sh (New)
Jim Simons 511,000 sh (+6.87%)
» More
Q4 2017

SLP Guru Trades in Q4 2017

Chuck Royce 377 sh (+4.14%)
Jim Simons 525,100 sh (+2.76%)
» More
Q1 2018

SLP Guru Trades in Q1 2018

Jim Simons 556,500 sh (+5.98%)
Chuck Royce 357 sh (-5.31%)
» More
» Details

Insider Trades

Latest Guru Trades with SLP

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Health Information Services    NAICS: 511210    SIC: 7372
Compare:XKRX:071200, NAS:NH, XKRX:032620, TSE:3733, OTCPK:MDXL, TSE:3649, XSAT:SYNT, TSE:3794, NAS:CPSI, TSE:4820, TSXV:RHT, TSE:6545, ROCO:6569, TSE:6095, TSE:6078, ASX:ONE, XKRX:032850, NZSE:OHE, XTER:M3V, XSWX:SHLTN » details
Traded in other countries:SD3.Germany,
Headquarter Location:USA
Simulations Plus Inc is a developer of drug discovery and development software for mechanistic modelling, simulation and machine learning based technologies. It also explores the application of machine learning technologies in other industries.

Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) Predictor is a computer program that takes molecular structures as inputs; MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures; MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules.

Top Ranked Articles about Simulations Plus Inc

US Stocks Surged in Pre-Market Tuesday Simulations Plus high on beating results
U.S. stock market traded high in Tuesday pre-market trading. The Dow Jones Industrial Average traded slightly above 24,450, advancing more than 400 points. Read more...

Ratios

vs
industry
vs
history
PE Ratio 37.81
SLP's PE Ratio is ranked lower than
70% of the 1288 Companies
in the Global Health Information Services industry.

( Industry Median: 27.61 vs. SLP: 37.81 )
Ranked among companies with meaningful PE Ratio only.
SLP' s PE Ratio Range Over the Past 10 Years
Min: 9.1  Med: 27.88 Max: 88.88
Current: 37.81
9.1
88.88
Forward PE Ratio 35.59
SLP's Forward PE Ratio is ranked lower than
74% of the 318 Companies
in the Global Health Information Services industry.

( Industry Median: 24.04 vs. SLP: 35.59 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 37.81
SLP's PE Ratio without NRI is ranked lower than
70% of the 1279 Companies
in the Global Health Information Services industry.

( Industry Median: 27.94 vs. SLP: 37.81 )
Ranked among companies with meaningful PE Ratio without NRI only.
SLP' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.1  Med: 28.06 Max: 88.88
Current: 37.81
9.1
88.88
Price-to-Owner-Earnings 64.82
SLP's Price-to-Owner-Earnings is ranked lower than
77% of the 749 Companies
in the Global Health Information Services industry.

( Industry Median: 27.98 vs. SLP: 64.82 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
SLP' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.31  Med: 29.32 Max: 147.95
Current: 64.82
7.31
147.95
PB Ratio 10.13
SLP's PB Ratio is ranked lower than
85% of the 1923 Companies
in the Global Health Information Services industry.

( Industry Median: 3.25 vs. SLP: 10.13 )
Ranked among companies with meaningful PB Ratio only.
SLP' s PB Ratio Range Over the Past 10 Years
Min: 1.34  Med: 5.03 Max: 14.63
Current: 10.13
1.34
14.63
PS Ratio 11.07
SLP's PS Ratio is ranked lower than
87% of the 1917 Companies
in the Global Health Information Services industry.

( Industry Median: 2.57 vs. SLP: 11.07 )
Ranked among companies with meaningful PS Ratio only.
SLP' s PS Ratio Range Over the Past 10 Years
Min: 1.63  Med: 7.12 Max: 14.51
Current: 11.07
1.63
14.51
Price-to-Free-Cash-Flow 57.26
SLP's Price-to-Free-Cash-Flow is ranked lower than
71% of the 689 Companies
in the Global Health Information Services industry.

( Industry Median: 28.70 vs. SLP: 57.26 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
SLP' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 6.85  Med: 29.49 Max: 307.73
Current: 57.26
6.85
307.73
Price-to-Operating-Cash-Flow 40.97
SLP's Price-to-Operating-Cash-Flow is ranked lower than
77% of the 889 Companies
in the Global Health Information Services industry.

( Industry Median: 20.00 vs. SLP: 40.97 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
SLP' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.09  Med: 20.61 Max: 50.79
Current: 40.97
5.09
50.79
EV-to-EBIT 31.25
SLP's EV-to-EBIT is ranked lower than
65% of the 1329 Companies
in the Global Health Information Services industry.

( Industry Median: 20.79 vs. SLP: 31.25 )
Ranked among companies with meaningful EV-to-EBIT only.
SLP' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.3  Med: 16.9 Max: 50.6
Current: 31.25
3.3
50.6
EV-to-EBITDA 24.72
SLP's EV-to-EBITDA is ranked lower than
66% of the 1441 Companies
in the Global Health Information Services industry.

( Industry Median: 16.23 vs. SLP: 24.72 )
Ranked among companies with meaningful EV-to-EBITDA only.
SLP' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.7  Med: 13.6 Max: 42
Current: 24.72
2.7
42
EV-to-Revenue 10.53
SLP's EV-to-Revenue is ranked lower than
84% of the 2002 Companies
in the Global Health Information Services industry.

( Industry Median: 2.59 vs. SLP: 10.53 )
Ranked among companies with meaningful EV-to-Revenue only.
SLP' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.8  Med: 6.3 Max: 14.3
Current: 10.53
0.8
14.3
PEG Ratio 2.15
SLP's PEG Ratio is ranked lower than
57% of the 603 Companies
in the Global Health Information Services industry.

( Industry Median: 2.18 vs. SLP: 2.15 )
Ranked among companies with meaningful PEG Ratio only.
SLP' s PEG Ratio Range Over the Past 10 Years
Min: 0.24  Med: 1.85 Max: 8.36
Current: 2.15
0.24
8.36
Shiller PE Ratio 77.89
SLP's Shiller PE Ratio is ranked lower than
77% of the 359 Companies
in the Global Health Information Services industry.

( Industry Median: 39.15 vs. SLP: 77.89 )
Ranked among companies with meaningful Shiller PE Ratio only.
SLP' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.5  Med: 43.12 Max: 204
Current: 77.89
14.5
204
Current Ratio 3.33
SLP's Current Ratio is ranked higher than
62% of the 1912 Companies
in the Global Health Information Services industry.

( Industry Median: 1.96 vs. SLP: 3.33 )
Ranked among companies with meaningful Current Ratio only.
SLP' s Current Ratio Range Over the Past 10 Years
Min: 0.24  Med: 5.98 Max: 20.72
Current: 3.33
0.24
20.72
Quick Ratio 3.33
SLP's Quick Ratio is ranked higher than
65% of the 1912 Companies
in the Global Health Information Services industry.

( Industry Median: 1.81 vs. SLP: 3.33 )
Ranked among companies with meaningful Quick Ratio only.
SLP' s Quick Ratio Range Over the Past 10 Years
Min: 0.2  Med: 5.52 Max: 20.72
Current: 3.33
0.2
20.72
Days Sales Outstanding 96.13
SLP's Days Sales Outstanding is ranked lower than
55% of the 1642 Companies
in the Global Health Information Services industry.

( Industry Median: 68.90 vs. SLP: 96.13 )
Ranked among companies with meaningful Days Sales Outstanding only.
SLP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.77  Med: 55.55 Max: 85.67
Current: 96.13
31.77
85.67
Days Payable 9.16
SLP's Days Payable is ranked lower than
90% of the 1444 Companies
in the Global Health Information Services industry.

( Industry Median: 45.06 vs. SLP: 9.16 )
Ranked among companies with meaningful Days Payable only.
SLP' s Days Payable Range Over the Past 10 Years
Min: 8.57  Med: 31.37 Max: 43.03
Current: 9.16
8.57
43.03

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.27
SLP's Dividend Yield % is ranked higher than
50% of the 1399 Companies
in the Global Health Information Services industry.

( Industry Median: 1.41 vs. SLP: 1.27 )
Ranked among companies with meaningful Dividend Yield % only.
SLP' s Dividend Yield % Range Over the Past 10 Years
Min: 1.02  Med: 2.5 Max: 7.34
Current: 1.27
1.02
7.34
Dividend Payout Ratio 0.47
SLP's Dividend Payout Ratio is ranked lower than
67% of the 883 Companies
in the Global Health Information Services industry.

( Industry Median: 0.32 vs. SLP: 0.47 )
Ranked among companies with meaningful Dividend Payout Ratio only.
SLP' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.61  Med: 0.85 Max: 1.39
Current: 0.47
0.61
1.39
3-Year Dividend Growth Rate 1.70
SLP's 3-Year Dividend Growth Rate is ranked lower than
65% of the 584 Companies
in the Global Health Information Services industry.

( Industry Median: 9.10 vs. SLP: 1.70 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
SLP' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 10.1
Current: 1.7
0
10.1
Forward Dividend Yield % 1.32
SLP's Forward Dividend Yield % is ranked higher than
51% of the 1332 Companies
in the Global Health Information Services industry.

( Industry Median: 1.58 vs. SLP: 1.32 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.43
SLP's 5-Year Yield-on-Cost % is ranked lower than
57% of the 1800 Companies
in the Global Health Information Services industry.

( Industry Median: 1.86 vs. SLP: 1.43 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
SLP' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.15  Med: 2.81 Max: 8.26
Current: 1.43
1.15
8.26
3-Year Average Share Buyback Ratio -1.90
SLP's 3-Year Average Share Buyback Ratio is ranked higher than
59% of the 1376 Companies
in the Global Health Information Services industry.

( Industry Median: -3.20 vs. SLP: -1.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SLP' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -4  Med: -1.5 Max: 0
Current: -1.9
-4
0

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 56.72
SLP's Price-to-Net-Current-Asset-Value is ranked lower than
99% of the 1165 Companies
in the Global Health Information Services industry.

( Industry Median: 7.81 vs. SLP: 56.72 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
SLP' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.74  Med: 8.06 Max: 306
Current: 56.72
1.74
306
Price-to-Tangible-Book 53.70
SLP's Price-to-Tangible-Book is ranked lower than
99% of the 1612 Companies
in the Global Health Information Services industry.

( Industry Median: 4.78 vs. SLP: 53.70 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
SLP' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.73  Med: 6.68 Max: 852.94
Current: 53.7
1.73
852.94
Price-to-Intrinsic-Value-Projected-FCF 3.98
SLP's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
70% of the 789 Companies
in the Global Health Information Services industry.

( Industry Median: 2.28 vs. SLP: 3.98 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
SLP' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.71  Med: 2.37 Max: 61
Current: 3.98
0.71
61
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.87
SLP's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
60% of the 129 Companies
in the Global Health Information Services industry.

( Industry Median: 1.82 vs. SLP: 1.87 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
SLP' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.99  Med: 1.67 Max: 2.66
Current: 1.87
0.99
2.66
Price-to-Median-PS-Value 1.55
SLP's Price-to-Median-PS-Value is ranked lower than
69% of the 1595 Companies
in the Global Health Information Services industry.

( Industry Median: 1.14 vs. SLP: 1.55 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
SLP' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.06  Med: 0.54 Max: 1.94
Current: 1.55
0.06
1.94
Price-to-Peter-Lynch-Fair-Value 1.78
SLP's Price-to-Peter-Lynch-Fair-Value is ranked lower than
64% of the 374 Companies
in the Global Health Information Services industry.

( Industry Median: 1.65 vs. SLP: 1.78 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
SLP' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.4  Med: 1.8 Max: 10.09
Current: 1.78
0.4
10.09
Price-to-Graham-Number 9.50
SLP's Price-to-Graham-Number is ranked lower than
99% of the 920 Companies
in the Global Health Information Services industry.

( Industry Median: 2.64 vs. SLP: 9.50 )
Ranked among companies with meaningful Price-to-Graham-Number only.
SLP' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.67  Med: 2.57 Max: 40.28
Current: 9.5
0.67
40.28
Earnings Yield (Greenblatt) % 3.20
SLP's Earnings Yield (Greenblatt) % is ranked higher than
59% of the 2098 Companies
in the Global Health Information Services industry.

( Industry Median: 1.99 vs. SLP: 3.20 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
SLP' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2  Med: 5.9 Max: 30
Current: 3.2
2
30
Forward Rate of Return (Yacktman) % 21.36
SLP's Forward Rate of Return (Yacktman) % is ranked higher than
88% of the 834 Companies
in the Global Health Information Services industry.

( Industry Median: 10.67 vs. SLP: 21.36 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
SLP' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 9.8  Med: 19 Max: 28.5
Current: 21.36
9.8
28.5

More Statistics

Revenue (TTM) (Mil) $29.25
EPS (TTM) $ 0.48
Beta-0.95
Volatility30.83%
52-Week Range $13.38 - 23.95
Shares Outstanding (Mil)17.37

Analyst Estimate

Aug18 Aug19
Revenue (Mil $) 28 31
EBIT (Mil $)
EBITDA (Mil $)
EPS ($) 0.48 0.51
EPS without NRI ($) 0.48 0.51
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAN
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}